NYSE: AMP - Ameriprise Financial

Yield per half year: +26.12%
Sector: Healthcare

Company Analysis Ameriprise Financial

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (41.77%) is higher than the sector average (-13.41%).
  • Current debt level 2.96% is below 100% and has decreased over 5 years from 3.25%.
  • The company's current efficiency (ROE=54.05%) is higher than the sector average (ROE=-80.87%)

Disadvantages

  • Price (316.4 $) is higher than fair price (304.57 $)
  • Dividends (1.26%) are below the sector average (1.28%).

Similar companies

Humana

UnitedHealth Group

Johnson & Johnson

Bristol-Myers

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Ameriprise Financial Healthcare Index
7 days 2.5% -12% -0.7%
90 days 15.2% -19.6% 4.1%
1 year 41.8% -13.4% 25.9%

AMP vs Sector: Ameriprise Financial has outperformed the "Healthcare" sector by 55.18% over the past year.

AMP vs Market: Ameriprise Financial has outperformed the market by 15.87% over the past year.

Stable price: AMP is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: AMP with weekly volatility of 0.8033% over the past year.

3. Summary of the report

3.1. General

P/E: 15.86
P/S: 2.61

3.2. Revenue

EPS 23.71
ROE 54.05%
ROA 1.46%
ROIC 0%
Ebitda margin -0.9913%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (316.4 $) is higher than the fair price (304.57 $).

Price is higher than fair: The current price (316.4 $) is 3.7% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (15.86) is lower than that of the sector as a whole (57.85).

P/E vs Market: The company's P/E (15.86) is lower than that of the market as a whole (47.37).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (8.57) is lower than that of the sector as a whole (9.39).

P/BV vs Market: The company's P/BV (8.57) is lower than that of the market as a whole (22.69).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (2.61) is lower than that of the sector as a whole (4.05).

P/S vs Market: The company's P/S indicator (2.61) is lower than that of the market as a whole (15.16).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (-251.49) is lower than that of the sector as a whole (17.49).

EV/Ebitda vs Market: The company's EV/Ebitda (-251.49) is lower than that of the market as a whole (17.77).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 13.41% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (13.41%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-69.16%).

5.4. ROE

ROE vs Sector: The company's ROE (54.05%) is higher than that of the sector as a whole (-80.87%).

ROE vs Market: The company's ROE (54.05%) is higher than that of the market as a whole (17.14%).

5.5. ROA

ROA vs Sector: The company's ROA (1.46%) is lower than that of the sector as a whole (6.7%).

ROA vs Market: The company's ROA (1.46%) is lower than that of the market as a whole (6.51%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).

6. Finance

6.1. Assets and debt

Debt level: (2.96%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 3.25% to 2.96%.

Excess of debt: The debt is not covered by net income, percentage 202.86%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 1.26% is below the average for the sector '1.28%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 1.26% has been steadily paid over the past 7 years, DSI=0.93.

Dividend growth: Company's dividend yield 1.26% has been growing over the last 5 years. Growth over 18 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (21.52%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Selling More insider purchases by 118.08% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
11.11.2024 Berman Walter Stanley
EXECUTIVE VP AND CFO
Sale 564.16 4 882 800 8 655
11.11.2024 Berman Walter Stanley
EXECUTIVE VP AND CFO
Purchase 165.41 4 135 250 25 000
30.08.2024 William Davies
Officer
Purchase 442.07 3 846 010 8 700
27.03.2024 Alvero Gumer
PRESIDENT-INSURANCE&ANNUITIES
Sale 437 721 924 1 652
27.03.2024 Alvero Gumer
PRESIDENT-INSURANCE&ANNUITIES
Purchase 123.37 522 472 4 235

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Ameriprise Financial

9.3. Comments